"Although clearly disappointed with the panel decision, we look forward to the FDA's final decision in September. We believe shareholders should continue to hold Delcath stock, in fact, we believe this is a great time to purchase more of our companies stock. If i had money to invest, I would be an investor in our companies stock right now.. value is unprecedented. We always continue to put shareholder value first, before our own value. Again, buying this stock would be a great investment right now."